This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Celanese (CE) Soars 6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Celanese (CE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here's Why You Should Retain Celanese (CE) in Your Portfolio
by Zacks Equity Research
Celanese (CE) gains on productivity actions, investments in high-return organic projects and synergies of acquisitions.
If You Invested $1000 in Celanese 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Here's How Much You'd Have If You Invested $1000 in Celanese a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Can Value Investors Choose Celanese (CE) Stock Now?
by Zacks Equity Research
Is Celanese (CE) a great pick from the value investor's perspective right now? Read on to know more.
Here's How Much You'd Have If You Invested $1000 in Celanese a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Celanese (CE) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Celanese's (CE) Q1 results benefit from increased pricing amid cost inflation in raw material, energy and logistics in the Engineered Materials unit.
Celanese (CE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of 23.39% and 11.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Q1 Earnings Slated on Apr 28: EMN, CE, HUN & OLN
by Anindya Barman
Chemical companies' Q1 results are likely to have been driven by higher demand and the benefits of strategic actions amid headwinds from input cost inflation. Let's see how EMN, CE, HUN and OLN are poised ahead of their earnings releases.
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese's (CE) Q1 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
Celanese (CE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PPG Industries (PPG) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
PPG Industries' (PPG) Q1 performance is likely to have benefited from cost actions and acquisitions. Raw material inflation and supply-chain issues are expected to have hurt results.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) gains on productivity actions, investments in high-return organic projects and synergies of acquisitions.
Celanese (CE) & Mitsubishi Wrap Up Restructuring of KEP
by Zacks Equity Research
Celanese (CE) will have greater access to original equipment manufacturers in Asia and more direct participation in major markets outside China post restructuring of KEP.
Eastman Chemical (EMN) Gains on Cost Actions and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-cutting and productivity actions and efforts to drive new business revenues from innovation.
Univar (UNVR) Inks Deal With Particle Dynamics, Boosts Portfolio
by Zacks Equity Research
Univar (UNVR) will provide United States and Canada customers with Particle Dynamics' compressible calcium and magnesium carbonates and microencapsulated vitamins and minerals.
DuPont (DD) Inks Deal to Divest Mobility & Materials for $11B
by Zacks Equity Research
DuPont's (DD) latest deal strengthens its foothold in the fields of electronics, water, industrial technologies, protection and next-gen automotive.
Celanese (CE) Q4 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Celanese's (CE) Q4 results benefit from an increase in pricing amid cost inflation in raw material, energy, and logistics.
Celanese (CE) Misses Q4 Earnings Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -2.77% and 1.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) to Invest $1B in Recycling Facility
by Zacks Equity Research
Eastman Chemical's (EMN) investment is a major step forward in its strategy to accelerate a circular economy globally.
Why Celanese (CE) Might Surprise This Earnings Season
by Zacks Equity Research
Celanese (CE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Celanese (CE) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
LyondellBasell (LYB) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q4 performance is likely to have benefited from strong consumer-driven demand and continued recovery in the durable goods market.
Sherwin-Williams (SHW) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Sherwin-Williams' (SHW) fourth-quarter performance is likely to reflect strong demand, pricing and cost-control initiatives.
Chemical Stock Q4 Earnings Due on Jan 27: DOW, EMN, CE & OLN
by Anindya Barman
Strong end-market demand and the benefits of strategic measures are likely to have aided the performance of chemical companies in Q4. Let's see how DOW, EMN, CE and OLN are poised ahead of their earnings releases.